Latest Mass Tort News and Updates

A motion filed by the manufacturer of Covidien hernia mesh products asking for consolidation was rejected by the U.S. Judicial Panel on Multidistrict Litigation (JPML),…

Taxotere lawsuits witnessed a spike with almost 219 cases filed between July and August, bringing the total to almost 1,500 cases pending in the U.S. District Court, Eastern District of Louisiana against Sanofi-Aventis. The lawsuits are filed by…

Another report released this August confirms that Monsanto was involved in influencing and curbing the release of damaging scientific data regarding the safety and efficacy of …

The third straight win for Xarelto defendants in the Xarelto MDL No. 2592 bellwether trial, boosts the defendant's stand regarding the safety and efficacy of Xarelto. Bayer released a statement saying, ''that its FDA-…

One of the largest verdicts was announced in favor of the plaintiff this August by a California jury: J&J was ordered to pay $417 which included $347 million in punitive damages and $70 million in compensatory damages, making it one of the…

The U.S. Food & Drug Administration (FDA) has finally given a go to Perrigo Company Plc., to market a store-brand equivalent of Nexium 24HR which is an OTC version of Nexium used to treat heartburns. Owing to…

Taxotere, a chemotherapy drug approved by the FDA for treating cancer in 1996, is currently the subject of several lawsuits in multiple states as the announcement hit the news that the first lawsuit filed under MDL…

In spite of a list of side effects linked to Onglyza, there is only some success or positive movement at the plaintiff's end. Last year, 14 of them had their claims dismissed by a federal judge in California who granted the defendant AstraZeneca'…

Invokana lawsuits have shown further movement in the court proceedings with the approval coming forth for the Plaintiff Fact Sheets along with its protocols details by the U.S. District Court, District of New…

As the PPI case filings seem to have significantly increased, the Judicial Panel on Multidistrict Litigation (JPML) took a decision to hear the argument of PPI litigations on July 27, 2017, under a new motion…